Status
Conditions
Treatments
About
This study will evaluate the efficacy of the DIME TBT Cream in improving the appearance and hydration of aged skin in comparison to a retinol cream. This study will last for 60 days. The study will be conducted as a single-arm trial in which all participants will use both the test product and the positive control product (0.1% Retinol Clinical Trial Lotion). Participants will be required to undertake questionnaires at Baseline, Day 30, and Day 60. Photos will be taken at Baseline, Day 30, and Day 60, and expert skin grading will take place at Baseline and Day 60.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Females aged 18-65. Have one or more of the following: visible fine lines and wrinkles, dry skin, reduced skin elasticity, or generally unhealthy skin.
Must be willing to use two different skincare products, one on each side of their face for the duration of the trial.
Have a smartphone or camera to take before-and-after selfies.
Exclusion criteria
Anyone not in good health. Anyone who has any chronic health conditions such as oncological or psychiatric disorders.
Anyone who has any known serious allergic reactions that require the use of an Epi-Pen.
Anyone who is pregnant, breastfeeding, or wanting to become pregnant over the next three months.
Anyone who cannot/ will not commit to the study protocol. Anyone with a history of substance abuse.
Primary purpose
Allocation
Interventional model
Masking
35 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal